McDermott Advises Silverfleet Capital on the Sale of Medical Workwear Innovators 7days to Chequers Capital and Paragon Partners
Munich, November 30, 2020 – McDermott Will & Emery advises the pan-European private equity firm Silverfleet Capital on the sale of its portfolio company 7days to a consortium of investors comprising Chequers Capital and Paragon Partners. Subject to regulatory approvals the transaction is expected to close in January 2021.
7days, founded in 1999, is a leading supplier of modern and innovative medical workwear. The company designs, manufactures and distributes a wide range of high-quality products for more than 300,000 customers in the healthcare sector in 12 countries, including Germany, Austria, Switzerland, France, Belgium, the Netherlands and Scandinavia.
Silverfleet invested in 7days from its mid-market fund in 2018, and has since then developed and implemented a successful transformation and internationalization strategy for the company. This included also the acquisition of Praxis Herning A/S, a Danish supplier of medical workwear in Scandinavia.
Silverfleet Capital has been active as a private equity investor in the European mid-market for more than 30 years. A team of 31 investment professionals working from Munich, Amsterdam, London, Paris and Stockholm focuses on industries such as financial services, healthcare, manufacturing, retail and consumer goods.
Lead partner Tobias Koppmann previously advised Silverfleet Capital on the acquisition of the 7days Group, and McDermott also advised Silverfleet Capital on the acquisition of Praxis Herning A/S at the end of 2018.
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective—and often unexpected—solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.